Ritujith Jayakrishnan

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Ritujith Jayakrishnan

Feb 12, 2025, 16:19 | Science

Aakash Desai: ICB Retreatment in NSCLC - Who Benefits?

Aakash Desai, Assistant Professor at UAB O’Neal Comprehensive Cancer Center, shared on LinkedIn about recent…

Sep 24, 2024, 13:32 | Insight

Jarushka Naidoo: Stage III ALK+ NSCLC - consolidation ALK TKI vs Durvalumab vs Observation

Jarushka Naidoo shared on X: "Stage III ALK+ NSCLC: consolidation ALK Tyrosine Kinase Inhibitors versus…

Apr 5, 2024, 07:53 | Blog

Rafeh Naqash: Couldn’t be more happy to see this project led by the one and only Amin Nassar to be selected for Rapid Oral ASCO24

Rafeh Naqash, Assistant Professor at OU Health Stephenson Cancer Center, shared a post on X:…

All: 3 Posts: 1 - 100

'

Where to Study to Become ASCO President: 2025 Institutional Rankings

'

Yelak Biru: UK grants first approval for Blenrep in multiple myeloma

'

Eric Abidal and Liver Cancer: How He Returned to Football After Overcoming Illness

'

Dr. Don Dizon and Dr. Nathan Pennell Reflect on the Evolution of the ASCO Educational Book

'

April is Head and Neck Cancer Awareness Month

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023